Advanced search

Presently, Jeremiah Alphonsus O'Callaghan is Chairman for JBS SA and Co-Managing Director at JBS Investments II GmbH and Investor Relations Officer at JBS Foods International (both are subsidiaries of JBS SA). He is also on the board of JBS Investments UK Ltd. He received an undergraduate degree from University College Cork.

Currently, Jeremiah Brazeau is Chief Technology Officer of Twilio, Inc. He previously held the position of Senior Vice President & Distinguished Architect at salesforce.com, inc. He received an undergraduate degree and a graduate degree from Rochester Institute of Technology and a graduate degree from Northeastern University.

Barbara S. Jeremiah is Chairman-Designate at The Weir Group Plc. She is also Member of the University of Virginia and on the board of 6 other companies. In the past she held the position of Chairman of Boart Longyear Ltd., Executive Vice President at Alcoa Corp. and Executive Vice President-Corporate Development at Alcoa, Inc. She received an undergraduate degree from Brown University and a graduate degree from the University of Virginia School of Law.

Alphonsus Walder is currently the Chief Executive Officer at Baronie-de Heer BV, Co-Managing Director at Stollwerck Norderstedt GmbH & Co. KG, Director at Belgian Ice Cream Group NV, Director at Glacio NV, Managing Director & Director at Baronie Productie NV, and Managing Director & Director at Sweet Products NV.
He previously held the position of Co-Managing Director at Stollwerck Schokoladen Vertriebs GmbH.

Alphonsus Moniz worked as a Portfolio Manager at P.
Schoenfeld Asset Management LP from 2017 to 2019 and as a Partner & Portfolio Manager at Fore Research & Management LP from 2003 to 2017.
He holds a graduate degree from Boston College, an MBA from Cochin University of Science & Technology, and an undergraduate degree from Visvesvaraya College of Engineering.

Alphonsus A.
Okoye is a member of the Chartered Insurance Institute of Nigeria and the Chartered Institute of Marketing of Nigeria.
He was previously the General Manager & Head-Eastern Operations at Guinea Insurance Plc.
He completed his undergraduate degree at the University of Port-Harcourt and his MBA at the University of Calabar.
Dr. Okoye's current job(s) are with the Chartered Insurance Institute of Nigeria and the Chartered Institute of Marketing of Nigeria, where he holds the title of Member.

Michael P.
O'Callaghan worked as a Vice President at Rubenstein Partners LP from 2006 to 2010.

Mr. Shea O’Callaghan is a Research Associate at Mackie Research Capital Corp.

Lawrence R.
O’Callaghan is currently a Director at Missouri Valley REIT, Inc. He was previously a Trustee at Sterling Real Estate Trust from 2003 to 2013.

Michael O'Callaghan is an economist who currently works at The Economic & Social Research Institute.

James O'Callaghan has a current job as a Director at The Stable Group LLC.

Luc O'Callaghan has a current job as the Head of Credits & Commitments at Banque Dupuy de Parseval SA.

Mr. O’Callaghan founded CPI, a pioneer in the recruiting industry, in 1996.
He has been fortunate to work with successful investment firms and their portfolio companies, helping them hire talent and manage the intricacies of managing, empowering and inspiring teams.
Brian has been involved with several entrepreneurial ventures acting as a founder, investor and advisor including, most recently, the Autism Impact Fund.
CPI is 41 people in 4 cities working closely together to provide clients access to talent through our extraordinary network, while sharing useful information and counsel.
DEI hiring and retention is a Firm-wide passion that we focus on every day.
Brian manages CPI and helps execute projects at all levels.
With the support and leadership of his talented colleagues, Brian has helped nurture a close, collaborative and entrepreneurial culture.
The team works selflessly together, sharing the brain share and resources of the Firm with clients.
Prior to founding CPI, Brian was a Vice President with Jones Lang LaSalle and an Analyst with Morgan Stanley in the Investment Banking Real Estate Group.
Brian is a graduate of The Lawrenceville School and Denison University.
He is a member of the Board of Berkshire School and King School.

Caroline Jaqueline Michele O'Callaghan worked as an Investment Director at Rathbones Investment Management Ltd.
from 2012 to 2016.

Scott O'Callaghan is an Independent Director at North Mountain Merger Corp.
He previously worked as a Managing Director at MidOcean US Advisor LP from 2009 to 2010, and as an Independent Director at South Mountain Merger Corp.
from 2020 to 2021.
He also held Principal positions at Drexel Burnham Lambert Real Estate Associates II, Deutsche Bank Investment Management, Inc., and Bankers Trust & Co. Additionally, he was Head-Leveraged Sales at Bank of America Corp.
in 2009.
O'Callaghan received his undergraduate degree from Brown University in 1986.

Matt E.
O'Callaghan worked as an Analyst at Mariner Investment Group LLC from 2000 to 2002.
He also worked as an Analyst at Pirate Capital LLC.
Later, he worked as a Senior Bank Loan Trader at Odeon Capital Group LLC from 2011 to 2015.
O'Callaghan received his undergraduate degree from the University of St. Thomas in 1999.

Brian O'Callaghan was the founder and had founded Biopartners GmbH in 2000, where he served as the President & Chief Executive Officer until 2004.
He is currently the Chief Executive Officer & Director at Deep Genomics, Inc. since 2023, Director at BIOCOM since 2013, Director at Century Club of San Diego, Independent Director at Bolt Biotherapeutics, Inc. since 2021, and Director at Petra Pharma Corp.
since 2017.
Mr. O'Callaghan has held former positions as the President, Chief Executive Officer & Director at Sangart, Inc. from 2008 to 2014, President, Chief Executive Officer & Director at Acucela, Inc. in 2013, Chief Executive Officer at Sonrgy, Inc. from 2015 to 2017, Chief Commercial Officer at NPS Pharmaceuticals, Inc. from 2007 to 2008, General Manager at Labcorp Drug Development, Inc., General Manager at Merck KGaA, GM-North American Transplantation & Immunology at Novartis Pharmaceuticals Corp.
from 2004 to 2006, and Chief Executive & Financial Officer at Kubota Pharmaceutical Holdings Co. Ltd.
Mr. O'Callaghan also served as a Director at Aquavit Pharmaceuticals, Inc., Intec Pharma Ltd., ObsEva SA from 2020 to 2023, and Decoy Biosystems, Inc., as well as an Independent Director at Indaptus Therapeutics, Inc. He holds an MBA from The HENLEY College.

Mr. Shannon O'Callaghan is an Analyst at UBS Securities LLC.
Mr. O'Callaghan was previously employed as a Managing Director by Nomura Securities International, Inc., an Analyst by Credit Agricole Securities (USA), Inc., Barclays Capital, Inc., and a Lehman Brothers, Inc. He received his undergraduate degree from Boston College, a graduate degree from Boston College and an MBA from Massachusetts Institute of Technology.

Trent O'Callaghan has worked as a Manager-Sales Engineer at Nextgen Networks Pty Ltd since 2012.

John F.
O’Callaghan is currently the EVP, Global Head-Field Marketing & Operations at Triton International Ltd.
Prior to this, he worked at Triton Container International Ltd.
for 22 years, where his last position was Senior VP-Europe & North America Subcontinent.
He obtained his undergraduate degree from Trinity College Dublin.

John J.
O'Callaghan has worked as a Director at Gottlieb Memorial Hospital and Loyola University Health System.

Patricia O'Callaghan is currently the Chief Executive Officer of Gold Coast Tourism Corp Ltd.
She is also a Director at Queensland Country Bank Ltd.
and Queensland Country Health Fund Ltd.

Michael O'Callaghan is currently a member of the Governors Board at the Business Council of British Columbia.